Abstract:Fifteen new polyprenylated acylphloroglucinols (1—15, PPAPs), along with 36 known PPAP derivatives were obtained from Hypericum kouytchense. Compound 1 was a rare PPAP with a fused 6/6/6/5/5 pentacyclic ring system. The primary mechanistic study of compound 34, implied that this compound could prohibit the function of P‐gp transport rather than its expression. Comprehensive Summary Given the lack of systematic polyprenylated acylphloroglucinols (PPAPs) research on traditional Chinese medicine of Hypericum kouytchense, this plant was applied for the phytochemical study, which led to fifteen new PPAPs (1—15, PPAPs), along with 36 known PPAP derivatives. Their structures and absolute configurations were established by comprehensive spectral analysis and theoretical ECD and NMR calculations. Structurally, compound 1 possesses a rare fused 6/6/6/5/5 pentacyclic ring system. Eleven compounds exhibited good multidrug resistance reversal activity (RF ranging from 5 to 53) in HepG2/ADR cells. Importantly, compound 34, the most potential MDR modulator, showed better reversal effect (RF: 53) than positive control, verapamil. The primary mechanistic study of compound 34, implied that this compound could prohibit the function of P‐gp transport rather than its expression. The possible recognition mechanism between compound 34 and P‐gp was predicted by molecular docking.

Hyperascyrones A–H, Polyprenylated Spirocyclic Acylphloroglucinol Derivatives from Hypericum Ascyron Linn.

Ascyrones A-E, type B bicyclic ployprenylated acylphloroglucinol derivatives from Hypericum ascyron

Hypersampsones S–W, New Polycyclic Polyprenylated Acylphloroglucinols from Hypericum Sampsonii

Hyparillums A and B: polycyclic polyprenylated acylphloroglucinols from Hypericum patulum

Two rearranged acylphloroglucinols with moderate neuroprotective effects from Hypericum ascyron Linn.

Hyperacmosins K–M, three new polycyclic polyprenylated acylphloroglucinols from Hypericum acmosepalum

Hyperispirones A and B, spiro-bridged polycyclic polyprenylated acylphloroglucinols with anti-angiogenesis activity from <i>Hypericum beanii</i>

Kiiacylphnols A−H, eight undescribed polycyclic polyprenylated acylphloroglucinols with anticancer activities from Hypericum przewalskii Maxim

Polycyclic Polyprenylated Acylphloroglucinol Congeners Possessing Diverse Structures from Hypericum Henryi

Polycyclic Polyprenylated Acylphloroglucinols with Immunosuppressive Activity from Hypericum Perforatum and Absolute Configurations Assignment of Previously Reported Analogues.

Hypersonins A-D, Polycyclic Polyprenylated Acylphloroglucinols with a 1,2-<i>seco</i>-Homoadamantane Architecture from <i>Hypericum wilsonii</i>

Hyperpatulones C-G, new spirocyclic polycyclic polyprenylated acylphloroglucinols from the leaves of Hypericum patulum

Hypersampones A-C, Three Nor-Polycyclic Polyprenylated Acylphloroglucinols with Lipid-Lowering Activity from Hypericum sampsonii

Polyprenylated acylphloroglucinols from Hypericum sampsonii with cytotoxicity against pancreatic carcinomas

Discovery of bioactive polycyclic polyprenylated acylphloroglucinols with adamantine/homoadamantane skeletons from Hypericum wilsonii

Hyperkouytones A—O, New Polyprenylated Acylphloroglucinols from Hypericum kouytchense with Multidrug Resistance Reversal Activity

Discovery of 13,15-nor-polycyclic Polyprenylated Acylphloroglucinols from Hypericum Longistylum with Anti-Inflammatory Activity.

Three new decarbonyl prenylphloroglucinols bearing unusual spirost subunits from Hypericum scabrum and their neuronal activities

(±)-Hypandrone A, a Pair of Polycyclic Polyprenylated Acylphloroglucinol Enantiomers with a Caged 7/6/5/6/6 Pentacyclic Skeleton from Hypericum Androsaemum

Hyperattenins L and M, Two New Polyprenylated Acylphloroglucinols with Adamantyl and Homoadamantyl Core Structures from Hypericum Attenuatum.

Hypseudone A, a Hyperforin-Derived Polycyclic Polyprenylated Acylphloroglucinol with Caged Skeleton from Hypericum pseudohenryi